WHO ICTRP trial
A Randomized Controlled Study of Vonolasen Therapy and Bismuth-containing…
ChiCTR2200056375 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2200056375 |
|---|---|
| Public title | A Randomized Controlled Study of Vonolasen Therapy and Bismuth-containing Quadruple Therapy in Patients with H.pylori Infection |
| Scientific title | A Randomized Controlled Study of Vonolasen Therapy and Bismuth-containing Quadruple Therapy in Patients with H.pylori Infection |
| Primary sponsor | The University of Hong Kong Shenzhen Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | china |
| Conditions | Helicobacter pylori infection |
| Interventions | Dual therapy:Vonolasheng-Amoxicillin: Vonolasheng 20mg bid, amoxicillin 1g tid, course of treatment for 14 days;Triple therapy:Vonolasheng-Amoxicillin-Clarithromycin: Vonolasheng 20mg bid, amoxicillin 1g bid, clarithromycin 0.5g bid… |
| Registration date | Feb 4, 2022 |
| Target size | Dual therapy:109;Triple therapy:109;Quadruple Therapy:109 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: